Cargando…
The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
Methylation can occur in both histones and non-histones. Key lysine and arginine methyltransferases under investigation for renal disease treatment include enhancer of zeste homolog 2 (EZH2), G9a, disruptor of telomeric silencing 1-like protein (DOT1L), and protein arginine methyltransferases (PRMT)...
Autores principales: | Zhou, Xun, Chen, Hui, Li, Jinqing, Shi, Yingfeng, Zhuang, Shougang, Liu, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086358/ https://www.ncbi.nlm.nih.gov/pubmed/35559246 http://dx.doi.org/10.3389/fphar.2022.885527 |
Ejemplares similares
-
Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
por: Yu, Chao, et al.
Publicado: (2019) -
Protein arginine methyltransferases in renal development, injury, repair, and fibrosis
por: Yu, Jianjun, et al.
Publicado: (2023) -
The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
por: Zhou, Xun, et al.
Publicado: (2021) -
The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms
por: Zhang, Yuxiang, et al.
Publicado: (2023) -
The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)